Sarcopenia: Biomarkers and imaging (International Conference on Sarcopenia research)

1. Gerontopole Toulouse, Department of Geriatric Medicine, Toulouse University Hospital, Toulouse France, INSERM 1027; 2. Vice President, Clinical Research & Operations, Neuroscience & Neuromuscular Disorders, Cytokinetics, Inc. 280 East Grand Avenue, South San Francisco, CA 94080, USA; 3. Neurotune AG, Wagistr. 27A, 8952 Schlieren, Switzerland; 4. Senior Scientist and Director, Nutrition, Exercise Physiology, and Sarcopenia Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging, Tufts University, Boston, MA 02111 USA; 5. Department of Medicine, University of Pittsburgh, USA; 6. Human Medicine Special Areas, Scientific Advice Section, European Medicines Agency (EMA), 7 Westferry Circus, Canary Wharf, London E14 4HB UK; 7. Novartis Institutes for Biomedical Research, Fabrikstrasse 10-2.40.4, CH-4056 Basel, Switzerland; 8. Division of Geriatric Medicine, Saint Louis University School of Medicine and GRECC, VA Medical Center, St. Louis, Missouri USA; 9. Department of Aging and Geriatric Research and Institute on Aging, University of Florida, 1329 SW 16th Street, Room 5161, Gainesville, FL 32608, PO Box 100107, zip 32610-0107, USA; 10.Translational Medicine, Cambridge, MA, USA; 11. Associate Professor of Neurology, Harvard Medical School, Boston, Massachusetts, USA